Ozempic craze sends beer and snack stocks plummeting

  • 📰 nypost
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 67%

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen

Today's Business Headlines: 10\/6\/23

New Ozempic danger: FDA updates label to warn users of intestinal blockageOzempic and Wegovy which are being touted for their weight loss and appetite-suppressing benefitsSwiss snacking conglomerate Nestle’s share price dropped by more than 2.5% on Friday while Mondelez International, the company behind brand names such as Oreo and Chips Ahoy, saw its stock drop by 2.7% as of 2:20 p.m. Eastern time.

The stock price of Constellation Brands, the US distributor of Modelo Especial, which has recently overtaken Bud Light as the nation’s most popular beer, is down 1.3% on Friday. “We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” Furner told

With those data sets, the Bentonville, Ark.-based can see how many customers are on diabetes-turned-weight-loss drugs like Ozempic, Wegovy, and Mounjaro and compare their shopping habits to those not taking the medications.The stock price for Oreo maker Mondelez International fell on Friday by some 2.7% as of 2:45 p.m. Eastern time.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 91. in DE
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

How weight loss drugs like Ozempic could radically reshape the food businessInvestors and execs are closely watching what happens as Americans using these drugs eat less food.
Herkunft: axios - 🏆 302. / 63 Weiterlesen »